Monte Rosa Therapeutics (GLUE) Other Accumulated Expenses (2020 - 2025)
Monte Rosa Therapeutics (GLUE) recorded Other Accumulated Expenses of $4.42 million in Q1 2025, up 104.7% from $2.16 million a year earlier and up 31.8% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
At the end of FY2024, Monte Rosa Therapeutics reported Other Accumulated Expenses of $3.35 million, up 100.7% from FY2023.
- Annual Other Accumulated Expenses has a four-year compound annual growth rate of 24.4% (FY2020 to FY2024).
- Across earlier years, Other Accumulated Expenses came in at $1.67 million in FY2023 (-66.7%), $5.02 million in FY2022 (+497.6%), $840,000 in FY2021 (-40.0%) and $1.4 million in FY2020.
- The Q1 2025 figure is the highest quarterly Other Accumulated Expenses since Q4 2022.
- On a year-over-year basis, Other Accumulated Expenses rose in two of the last six quarters, with growth averaging 3.2%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 497.6% in Q4 2022, against a decline of 66.7% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.35 million (Q4 2024), $1.3 million (Q3 2024) and $1.95 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Monte Rosa Therapeutics | 894.88 Mn | 306.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 2.91 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 5.02 Mn |
| Dec 31, 2021 | 840,000.00 |
| Dec 31, 2020 | 1.40 Mn |
API Access
Monte Rosa Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();